Manuel A. Navia

About

Manuel A. Navia is a biomedical scientist and industry advisor whose work is associated with structural biology and drug resistance research. Accessible public records place him on the board of Altus Pharmaceuticals, on the trustee roster of Andover Newton Seminary at Yale Divinity School, and as a 2016 Gordon Research Conference chair in Drug Resistance. A policy report from the Committee for Economic Development cites his 1989 Nature paper on the HIV-1 protease structure, underscoring his scientific profile rather than a capital-deployment role.

Areas of interest